EP3204012 - CORTEXOLONE 17ALPHA-BENZOATE FOR USE IN THE TREATMENT OF TUMOURS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 09.04.2021 Database last updated on 13.07.2024 | |
Former | The patent has been granted Status updated on 01.05.2020 | ||
Former | Grant of patent is intended Status updated on 01.01.2020 | ||
Former | Request for examination was made Status updated on 14.07.2017 | ||
Former | The international publication has been made Status updated on 26.04.2017 | Most recent event Tooltip | 08.07.2022 | Lapse of the patent in a contracting state New state(s): MK | published on 10.08.2022 [2022/32] | Applicant(s) | For all designated states Cosmo Technologies Ltd Riverside II Sir John Rogerson's Quay Dublin 2 / IE | [2017/33] | Inventor(s) | 01 /
GERLONI, Mara 2933 Ariane Drive San Diego, California 2117 / US | [2017/33] | Representative(s) | FRKelly Waterways House Grand Canal Quay Dublin D02 PD39 / IE | [N/P] |
Former [2020/23] | FRKelly 27 Clyde Road Dublin D04 F838 / IE | ||
Former [2017/33] | Hally, Anna-Louise FRKelly 27 Clyde Road Dublin D04 F838 / IE | Application number, filing date | 15775455.7 | 07.10.2015 | [2017/33] | WO2015EP73176 | Priority number, date | EP20140188063 | 08.10.2014 Original published format: EP 14188063 | [2017/33] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016055537 | Date: | 14.04.2016 | Language: | EN | [2016/15] | Type: | A1 Application with search report | No.: | EP3204012 | Date: | 16.08.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 14.04.2016 takes the place of the publication of the European patent application. | [2017/33] | Type: | B1 Patent specification | No.: | EP3204012 | Date: | 03.06.2020 | Language: | EN | [2020/23] | Search report(s) | International search report - published on: | EP | 14.04.2016 | Classification | IPC: | A61K31/573, A61P35/00 | [2017/33] | CPC: |
A61K31/573 (EP,CN,IL,KR,US);
C07J5/0053 (EP,CN,IL,KR,US);
A61K45/06 (IL,US);
A61K9/0019 (IL,US);
A61K9/0053 (IL,US);
A61P35/00 (EP,KR);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/33] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | Title | German: | CORTEXOLON-17ALPHA-BENZOAT VERWENDUNG BEI DER BEHANDLUNG VON TUMOREN | [2020/01] | English: | CORTEXOLONE 17ALPHA-BENZOATE FOR USE IN THE TREATMENT OF TUMOURS | [2017/33] | French: | CORTEXOLONE-17ALPHA-BENZOATE POUR UTILISATION DANS LE TRAITEMENT DE TUMEURS | [2020/01] |
Former [2017/33] | CORTEXOLON-17ALPHA-BENZOAT ZUR VERWENDUNG IN DER BEHANDLUNG VON TUMOREN | ||
Former [2017/33] | 17-ALPHA-BENZOATE DE CORTEXOLONE DESTINÉ À ÊTRE UTILISÉ DANS LE TRAITEMENT DE TUMEURS | Entry into regional phase | 26.04.2017 | National basic fee paid | 26.04.2017 | Designation fee(s) paid | 26.04.2017 | Examination fee paid | Examination procedure | 26.04.2017 | Examination requested [2017/33] | 26.04.2017 | Date on which the examining division has become responsible | 01.12.2017 | Amendment by applicant (claims and/or description) | 02.01.2020 | Communication of intention to grant the patent | 23.04.2020 | Fee for grant paid | 23.04.2020 | Fee for publishing/printing paid | 23.04.2020 | Receipt of the translation of the claim(s) | Opposition(s) | 04.03.2021 | No opposition filed within time limit [2021/19] | Fees paid | Renewal fee | 31.07.2017 | Renewal fee patent year 03 | 26.10.2018 | Renewal fee patent year 04 | 22.10.2019 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 07.10.2015 | AL | 03.06.2020 | AT | 03.06.2020 | CY | 03.06.2020 | CZ | 03.06.2020 | DK | 03.06.2020 | EE | 03.06.2020 | FI | 03.06.2020 | HR | 03.06.2020 | LT | 03.06.2020 | LV | 03.06.2020 | MC | 03.06.2020 | MK | 03.06.2020 | MT | 03.06.2020 | PL | 03.06.2020 | RO | 03.06.2020 | RS | 03.06.2020 | SE | 03.06.2020 | SI | 03.06.2020 | SK | 03.06.2020 | SM | 03.06.2020 | TR | 03.06.2020 | BG | 03.09.2020 | NO | 03.09.2020 | GR | 04.09.2020 | IS | 03.10.2020 | PT | 06.10.2020 | IE | 07.10.2020 | LU | 07.10.2020 | BE | 31.10.2020 | CH | 31.10.2020 | LI | 31.10.2020 | [2022/32] |
Former [2022/27] | HU | 07.10.2015 | |
AL | 03.06.2020 | ||
AT | 03.06.2020 | ||
CY | 03.06.2020 | ||
CZ | 03.06.2020 | ||
DK | 03.06.2020 | ||
EE | 03.06.2020 | ||
FI | 03.06.2020 | ||
HR | 03.06.2020 | ||
LT | 03.06.2020 | ||
LV | 03.06.2020 | ||
MC | 03.06.2020 | ||
MT | 03.06.2020 | ||
PL | 03.06.2020 | ||
RO | 03.06.2020 | ||
RS | 03.06.2020 | ||
SE | 03.06.2020 | ||
SI | 03.06.2020 | ||
SK | 03.06.2020 | ||
SM | 03.06.2020 | ||
TR | 03.06.2020 | ||
BG | 03.09.2020 | ||
NO | 03.09.2020 | ||
GR | 04.09.2020 | ||
IS | 03.10.2020 | ||
PT | 06.10.2020 | ||
IE | 07.10.2020 | ||
LU | 07.10.2020 | ||
BE | 31.10.2020 | ||
CH | 31.10.2020 | ||
LI | 31.10.2020 | ||
Former [2021/46] | AL | 03.06.2020 | |
AT | 03.06.2020 | ||
CZ | 03.06.2020 | ||
DK | 03.06.2020 | ||
EE | 03.06.2020 | ||
FI | 03.06.2020 | ||
HR | 03.06.2020 | ||
LT | 03.06.2020 | ||
LV | 03.06.2020 | ||
MC | 03.06.2020 | ||
PL | 03.06.2020 | ||
RO | 03.06.2020 | ||
RS | 03.06.2020 | ||
SE | 03.06.2020 | ||
SI | 03.06.2020 | ||
SK | 03.06.2020 | ||
SM | 03.06.2020 | ||
BG | 03.09.2020 | ||
NO | 03.09.2020 | ||
GR | 04.09.2020 | ||
IS | 03.10.2020 | ||
PT | 06.10.2020 | ||
IE | 07.10.2020 | ||
LU | 07.10.2020 | ||
BE | 31.10.2020 | ||
CH | 31.10.2020 | ||
LI | 31.10.2020 | ||
Former [2021/37] | AL | 03.06.2020 | |
AT | 03.06.2020 | ||
CZ | 03.06.2020 | ||
DK | 03.06.2020 | ||
EE | 03.06.2020 | ||
FI | 03.06.2020 | ||
HR | 03.06.2020 | ||
LT | 03.06.2020 | ||
LV | 03.06.2020 | ||
MC | 03.06.2020 | ||
PL | 03.06.2020 | ||
RO | 03.06.2020 | ||
RS | 03.06.2020 | ||
SE | 03.06.2020 | ||
SI | 03.06.2020 | ||
SK | 03.06.2020 | ||
SM | 03.06.2020 | ||
BG | 03.09.2020 | ||
NO | 03.09.2020 | ||
GR | 04.09.2020 | ||
IS | 03.10.2020 | ||
PT | 06.10.2020 | ||
LU | 07.10.2020 | ||
BE | 31.10.2020 | ||
CH | 31.10.2020 | ||
LI | 31.10.2020 | ||
Former [2021/36] | AL | 03.06.2020 | |
AT | 03.06.2020 | ||
CZ | 03.06.2020 | ||
DK | 03.06.2020 | ||
EE | 03.06.2020 | ||
FI | 03.06.2020 | ||
HR | 03.06.2020 | ||
LT | 03.06.2020 | ||
LV | 03.06.2020 | ||
MC | 03.06.2020 | ||
PL | 03.06.2020 | ||
RO | 03.06.2020 | ||
RS | 03.06.2020 | ||
SE | 03.06.2020 | ||
SI | 03.06.2020 | ||
SK | 03.06.2020 | ||
SM | 03.06.2020 | ||
BG | 03.09.2020 | ||
NO | 03.09.2020 | ||
GR | 04.09.2020 | ||
IS | 03.10.2020 | ||
PT | 06.10.2020 | ||
LU | 07.10.2020 | ||
BE | 31.10.2020 | ||
Former [2021/31] | AL | 03.06.2020 | |
AT | 03.06.2020 | ||
CZ | 03.06.2020 | ||
DK | 03.06.2020 | ||
EE | 03.06.2020 | ||
FI | 03.06.2020 | ||
HR | 03.06.2020 | ||
LT | 03.06.2020 | ||
LV | 03.06.2020 | ||
MC | 03.06.2020 | ||
PL | 03.06.2020 | ||
RO | 03.06.2020 | ||
RS | 03.06.2020 | ||
SE | 03.06.2020 | ||
SI | 03.06.2020 | ||
SK | 03.06.2020 | ||
SM | 03.06.2020 | ||
BG | 03.09.2020 | ||
NO | 03.09.2020 | ||
GR | 04.09.2020 | ||
IS | 03.10.2020 | ||
PT | 06.10.2020 | ||
LU | 07.10.2020 | ||
Former [2021/24] | AL | 03.06.2020 | |
AT | 03.06.2020 | ||
CZ | 03.06.2020 | ||
DK | 03.06.2020 | ||
EE | 03.06.2020 | ||
FI | 03.06.2020 | ||
HR | 03.06.2020 | ||
LT | 03.06.2020 | ||
LV | 03.06.2020 | ||
PL | 03.06.2020 | ||
RO | 03.06.2020 | ||
RS | 03.06.2020 | ||
SE | 03.06.2020 | ||
SI | 03.06.2020 | ||
SK | 03.06.2020 | ||
SM | 03.06.2020 | ||
BG | 03.09.2020 | ||
NO | 03.09.2020 | ||
GR | 04.09.2020 | ||
IS | 03.10.2020 | ||
PT | 06.10.2020 | ||
Former [2021/21] | AL | 03.06.2020 | |
AT | 03.06.2020 | ||
CZ | 03.06.2020 | ||
DK | 03.06.2020 | ||
EE | 03.06.2020 | ||
FI | 03.06.2020 | ||
HR | 03.06.2020 | ||
LT | 03.06.2020 | ||
LV | 03.06.2020 | ||
PL | 03.06.2020 | ||
RO | 03.06.2020 | ||
RS | 03.06.2020 | ||
SE | 03.06.2020 | ||
SK | 03.06.2020 | ||
SM | 03.06.2020 | ||
BG | 03.09.2020 | ||
NO | 03.09.2020 | ||
GR | 04.09.2020 | ||
IS | 03.10.2020 | ||
PT | 06.10.2020 | ||
Former [2021/10] | AL | 03.06.2020 | |
AT | 03.06.2020 | ||
CZ | 03.06.2020 | ||
EE | 03.06.2020 | ||
FI | 03.06.2020 | ||
HR | 03.06.2020 | ||
LT | 03.06.2020 | ||
LV | 03.06.2020 | ||
PL | 03.06.2020 | ||
RO | 03.06.2020 | ||
RS | 03.06.2020 | ||
SE | 03.06.2020 | ||
SK | 03.06.2020 | ||
SM | 03.06.2020 | ||
BG | 03.09.2020 | ||
NO | 03.09.2020 | ||
GR | 04.09.2020 | ||
IS | 03.10.2020 | ||
PT | 06.10.2020 | ||
Former [2021/09] | AL | 03.06.2020 | |
AT | 03.06.2020 | ||
CZ | 03.06.2020 | ||
EE | 03.06.2020 | ||
FI | 03.06.2020 | ||
HR | 03.06.2020 | ||
LT | 03.06.2020 | ||
LV | 03.06.2020 | ||
RO | 03.06.2020 | ||
RS | 03.06.2020 | ||
SE | 03.06.2020 | ||
SM | 03.06.2020 | ||
BG | 03.09.2020 | ||
NO | 03.09.2020 | ||
GR | 04.09.2020 | ||
PT | 06.10.2020 | ||
Former [2021/04] | AL | 03.06.2020 | |
FI | 03.06.2020 | ||
HR | 03.06.2020 | ||
LT | 03.06.2020 | ||
LV | 03.06.2020 | ||
RS | 03.06.2020 | ||
SE | 03.06.2020 | ||
BG | 03.09.2020 | ||
NO | 03.09.2020 | ||
GR | 04.09.2020 | ||
Former [2021/01] | FI | 03.06.2020 | |
HR | 03.06.2020 | ||
LT | 03.06.2020 | ||
LV | 03.06.2020 | ||
RS | 03.06.2020 | ||
SE | 03.06.2020 | ||
BG | 03.09.2020 | ||
NO | 03.09.2020 | ||
GR | 04.09.2020 | ||
Former [2020/51] | FI | 03.06.2020 | |
HR | 03.06.2020 | ||
LT | 03.06.2020 | ||
LV | 03.06.2020 | ||
RS | 03.06.2020 | ||
SE | 03.06.2020 | ||
NO | 03.09.2020 | ||
GR | 04.09.2020 | ||
Former [2020/50] | FI | 03.06.2020 | |
HR | 03.06.2020 | ||
LT | 03.06.2020 | ||
LV | 03.06.2020 | ||
SE | 03.06.2020 | ||
NO | 03.09.2020 | ||
GR | 04.09.2020 | ||
Former [2020/48] | FI | 03.06.2020 | |
LT | 03.06.2020 | ||
SE | 03.06.2020 | ||
NO | 03.09.2020 | ||
Former [2020/47] | LT | 03.06.2020 | |
NO | 03.09.2020 | Cited in | International search | [A]US3530038 (FLINES JAN DE, et al); |